TBPMF   $0.0192  0.53% Market Closed

Tetra Bio-Pharma Inc
Last Events:

2023-03-29 Trend pattern changed from канал to симметричный треугольник.

2023-03-29 Signal in Stochastic changed from bullish weakening to bearish. The stochastic indicator is in the oversold territory and it falls. These factors indicate that the downside potential still holds even though the market is oversold. Last signal: entry into the oversold zone.

2023-03-29 Signal in MACD changed from bearish weakening to bearish. Oscillator MACD is in the negative territory it's lower than the signal line and falls. These factors mean that negative mood prevails. Last signal: main and signal line crossing.

2023-03-29 Signal in RSI changed from bullish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: entrance to the overbought zone.

2023-03-29 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-02-08 the price crossed down the moving average line and trying to form a short-term downside trend.

2023-03-29 Signal in EMA20 changed from bullish reversal to bearish reversal. 2023-02-08 the price crossed down the moving average line and getting closer to the MA, which means that the short-term downside trend weakens.

2023-03-29 Trend pattern changed from симметричный треугольник to канал.

2023-03-29 Signal in Stochastic changed from bearish to bullish weakening. The stochastic indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.


Current temperature: 0.00
ST: 0, Cor:

Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi ActivelyBuy Sell -
macd ActivelyBuy Sell Sell
stoch Sell Sell -
ma20 - - -
ma50 Sell - -
ma100 Sell - -
Candlestick PatternDec. 1, 2022 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN CA88166Y1007
ceo Dr. Guy Chamberland M.Sc., Master Herbal
Website https://www.tetrabiopharma.com
Tetra Bio-Pharma Inc., a biopharmaceutical company, engages in the discovery and development of cannabinoid-derived drugs for inflammation, pain, ophthalmology, and oncology. The company develops PLENITUDE to treat cancer-related pain in advanced cancer patients; REBORN for the treatment of breakthrough cancer pain; Reduvo for chemotherapy-induced nausea and vomiting; ARDS-003 for the treatment of sepsis and prevention of acute respiratory distress syndrome; and SERENITY to treat cancer cachexia. It also develops PPP003 for painful dry eye and uveitis pain; and HCC011 for hepatocellular carcinoma. Tetra Bio-Pharma Inc. has an agreement with Cellvera Global Holdings LLC for the co-development of ARDS-003 as a combination product with Qifenda 400MG (Favipiravir), a commercial-stage broad-spectrum antiviral drug. The company is headquartered in Orléans, Canada.